Portfolio Holdings Detail for ISIN IE0009QS7W62
Stock Name / FundMSCI Wld Hlth US A
Issuer
Entity holding fund iShares V Public Limited Company
Entity Type
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerWHCA(EUR) Euronext Amsterdam

Holdings detail for RPRX

Stock NameRoyalty Pharma Plc
TickerRPRX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINGB00BMVP7Y09
LEI549300FGFN7VOK8BZR03

Show aggregate RPRX holdings

News associated with RPRX

Prudential Financial Inc. Has $488,000 Stake in Royalty Pharma plc (NASDAQ:RPRX)
Prudential Financial Inc. lowered its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 18,360 shares of the biopharmaceutical company’s stock after selling 955 shares during the period. Prudential Financial Inc.’s holdings in Royalty Pharma were worth $488,000 at the end of the […] - 2025-04-10 08:01:02
American Century Companies Inc. Boosts Holdings in Royalty Pharma plc (NASDAQ:RPRX)
American Century Companies Inc. grew its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 67,160 shares of the biopharmaceutical company’s stock after buying an additional 3,671 shares […] - 2025-04-10 07:26:56
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by JPMorgan Chase & Co.
JPMorgan Chase & Co. lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 8.2% in the 4th quarter, Holdings Channel reports. The firm owned 1,395,242 shares of the biopharmaceutical company’s stock after purchasing an additional 105,824 shares during the quarter. JPMorgan Chase & Co.’s holdings in Royalty Pharma were worth $35,593,000 at […] - 2025-04-08 07:44:55
Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX)
Schroder Investment Management Group lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 64.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 196,359 shares of the biopharmaceutical company’s stock after selling 354,483 shares during the quarter. Schroder Investment Management […] - 2025-04-06 08:29:08
Analysts Set Royalty Pharma plc (NASDAQ:RPRX) PT at $41.60
Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating […] - 2025-03-31 05:14:52
Stock Traders Buy High Volume of Royalty Pharma Put Options (NASDAQ:RPRX)
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) saw some unusual options trading on Thursday. Stock traders purchased 4,237 put options on the stock. This is an increase of 344% compared to the typical volume of 954 put options. Institutional Trading of Royalty Pharma Institutional investors and hedge funds have recently modified their holdings of […] - 2025-03-28 07:07:01
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Corient Private Wealth LLC
Corient Private Wealth LLC lifted its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 86.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 46,249 shares of the biopharmaceutical company’s stock after acquiring an additional 21,383 shares during the period. Corient Private Wealth LLC’s holdings in Royalty Pharma were worth $1,180,000 at the […] - 2025-03-27 08:10:50
Royalty Pharma plc (NASDAQ:RPRX) Stake Lowered by HighTower Advisors LLC
HighTower Advisors LLC decreased its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 173,411 shares of the biopharmaceutical company’s stock after selling 9,177 shares during the period. HighTower Advisors […] - 2025-03-20 07:45:04
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by M&T Bank Corp
M&T Bank Corp boosted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 25.2% during the 4th quarter, HoldingsChannel reports. The fund owned 23,467 shares of the biopharmaceutical company’s stock after buying an additional 4,718 shares during the period. M&T Bank Corp’s holdings in Royalty Pharma were worth $599,000 as of its most […] - 2025-03-13 07:47:00
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Victory Capital Management Inc.
Victory Capital Management Inc. raised its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 15.2% in the 4th quarter, HoldingsChannel.com reports. The fund owned 978,211 shares of the biopharmaceutical company’s stock after buying an additional 129,176 shares during the quarter. Victory Capital Management Inc.’s holdings in Royalty Pharma were worth $24,954,000 […] - 2025-03-11 08:58:55
State of Michigan Retirement System Buys 2,700 Shares of Royalty Pharma plc (NASDAQ:RPRX)
State of Michigan Retirement System boosted its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 16.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,400 shares of the biopharmaceutical company’s stock after purchasing an additional […] - 2025-03-10 08:44:52
Allworth Financial LP Raises Position in Royalty Pharma plc (NASDAQ:RPRX)
Allworth Financial LP lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 417.6% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,087 shares of the biopharmaceutical company’s stock after acquiring an additional 877 shares during the quarter. Allworth Financial LP’s holdings in Royalty Pharma were worth $28,000 as of […] - 2025-02-27 08:28:51
Royalty Pharma (NASDAQ:RPRX) Reaches New 52-Week High on Strong Earnings
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) shares reached a new 52-week high during mid-day trading on Tuesday following a stronger than expected earnings report. The stock traded as high as $32.72 and last traded at $32.15, with a volume of 1138540 shares traded. The stock had previously closed at $31.72. The biopharmaceutical company […] - 2025-02-12 06:37:01
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Mirae Asset Global Investments Co. Ltd.
Mirae Asset Global Investments Co. Ltd. decreased its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 1.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 75,068 shares of the biopharmaceutical company’s stock after selling 966 shares during […] - 2025-02-11 09:59:05
Royalty Pharma plc (NASDAQ:RPRX) Receives Consensus Rating of “Buy” from Brokerages
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has earned a consensus rating of “Buy” from the seven analysts that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has given a strong buy recommendation to […] - 2025-02-11 09:04:54
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Blue Trust Inc.
Blue Trust Inc. boosted its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 31.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,579 shares of the biopharmaceutical company’s stock after acquiring an additional 376 shares during the quarter. Blue Trust Inc.’s holdings […] - 2025-02-10 18:12:59

MSCI Wld Hlth US A RPRX holdings

DateNumber of RPRX Shares HeldBase Market Value of RPRX SharesLocal Market Value of RPRX SharesChange in RPRX Shares HeldChange in RPRX Base ValueCurrent Price per RPRX Share HeldPrevious Price per RPRX Share Held
2025-04-17 (Thursday)8,205USD 267,483USD 267,483
2025-04-16 (Wednesday)8,205USD 264,119RPRX holding decreased by -2133USD 264,1190USD -2,133 USD 32.19 USD 32.45
2025-04-15 (Tuesday)8,205USD 266,252RPRX holding increased by 1313USD 266,2520USD 1,313 USD 32.45 USD 32.2899
2025-04-14 (Monday)8,205USD 264,939RPRX holding increased by 2789USD 264,9390USD 2,789 USD 32.2899 USD 31.95
2025-04-11 (Friday)8,205USD 262,150RPRX holding increased by 6072USD 262,1500USD 6,072 USD 31.95 USD 31.21
2025-04-10 (Thursday)8,205USD 256,078RPRX holding decreased by -8697USD 256,0780USD -8,697 USD 31.21 USD 32.27
2025-04-09 (Wednesday)8,205USD 264,775RPRX holding increased by 11651USD 264,7750USD 11,651 USD 32.27 USD 30.85
2025-04-08 (Tuesday)8,205USD 253,124RPRX holding decreased by -1477USD 253,1240USD -1,477 USD 30.85 USD 31.03
2025-04-07 (Monday)8,205USD 254,601RPRX holding decreased by -657USD 254,6010USD -657 USD 31.03 USD 31.1101
2025-04-04 (Friday)8,205USD 255,258RPRX holding decreased by -1394USD 255,2580USD -1,394 USD 31.1101 USD 31.28
2025-04-02 (Wednesday)8,205USD 256,652RPRX holding increased by 902USD 256,6520USD 902 USD 31.28 USD 31.17
2025-04-01 (Tuesday)8,205USD 255,750RPRX holding increased by 328USD 255,7500USD 328 USD 31.17 USD 31.13
2025-03-31 (Monday)8,205USD 255,422RPRX holding decreased by -1969USD 255,4220USD -1,969 USD 31.13 USD 31.37
2025-03-28 (Friday)8,205USD 257,391RPRX holding decreased by -2297USD 257,3910USD -2,297 USD 31.37 USD 31.65
2025-03-27 (Thursday)8,205USD 259,688RPRX holding increased by 738USD 259,6880USD 738 USD 31.65 USD 31.56
2025-03-26 (Wednesday)8,205USD 258,950RPRX holding decreased by -18051USD 258,9500USD -18,051 USD 31.56 USD 33.76
2025-03-25 (Tuesday)8,205RPRX holding increased by 97USD 277,001RPRX holding increased by 3356USD 277,00197USD 3,356 USD 33.76 USD 33.75
2025-03-24 (Monday)8,108USD 273,645RPRX holding increased by 405USD 273,6450USD 405 USD 33.75 USD 33.7001
2025-03-21 (Friday)8,108USD 273,240RPRX holding increased by 1622USD 273,2400USD 1,622 USD 33.7001 USD 33.5
2025-03-20 (Thursday)8,108USD 271,618RPRX holding increased by 730USD 271,6180USD 730 USD 33.5 USD 33.41
2025-03-19 (Wednesday)8,108USD 270,888USD 270,8880USD 0 USD 33.41 USD 33.41
2025-03-18 (Tuesday)8,108USD 270,888RPRX holding increased by 3162USD 270,8880USD 3,162 USD 33.41 USD 33.02
2025-03-17 (Monday)8,108USD 267,726RPRX holding increased by 2027USD 267,7260USD 2,027 USD 33.02 USD 32.77
2025-03-14 (Friday)8,108USD 265,699RPRX holding increased by 730USD 265,6990USD 730 USD 32.77 USD 32.6799
2025-03-13 (Thursday)8,108USD 264,969RPRX holding decreased by -1379USD 264,9690USD -1,379 USD 32.6799 USD 32.85
2025-03-12 (Wednesday)8,108USD 266,348RPRX holding increased by 3162USD 266,3480USD 3,162 USD 32.85 USD 32.46
2025-03-11 (Tuesday)8,108USD 263,186RPRX holding decreased by -2351USD 263,1860USD -2,351 USD 32.46 USD 32.75
2025-03-10 (Monday)8,108USD 265,537RPRX holding decreased by -2108USD 265,5370USD -2,108 USD 32.75 USD 33.01
2025-03-07 (Friday)8,108RPRX holding decreased by -201USD 267,645RPRX holding decreased by -12950USD 267,645-201USD -12,950 USD 33.01 USD 33.77
2025-03-05 (Wednesday)8,309USD 280,595USD 280,595
2024-11-12 (Tuesday)10,755USD 279,630USD 279,630
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RPRX by for IE0009QS7W62

Show aggregate share trades of RPRX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-03-25BUY97 33.760* 33.11
2025-03-07SELL-201 33.010* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RPRX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-04-17707,1516221,108,50263.8%
2025-04-16783,5361,3271,099,70071.2%
2025-04-15650,53801,209,62853.8%
2025-04-14372,2251251,030,38736.1%
2025-04-11965,17302,476,00839.0%
2025-04-101,560,32103,048,63751.2%
2025-04-091,495,0301,3293,039,84749.2%
2025-04-081,497,4651122,191,95068.3%
2025-04-071,284,9508992,060,91962.3%
2025-04-041,554,7918182,880,16054.0%
2025-04-031,010,5071921,678,21560.2%
2025-04-02436,244861,664,28126.2%
2025-04-01721,3401071,981,44636.4%
2025-03-311,232,327433,701,24333.3%
2025-03-28900,4764761,544,72858.3%
2025-03-272,712,6331,4563,319,21681.7%
2025-03-263,911,6301,8985,270,48874.2%
2025-03-25716,57001,976,84636.2%
2025-03-24355,21089892,16539.8%
2025-03-21474,1661461,075,52144.1%
2025-03-20313,9370998,15131.5%
2025-03-19296,027591691,25342.8%
2025-03-18346,838391,131,37930.7%
2025-03-17353,24372810,44643.6%
2025-03-14460,04360877,98852.4%
2025-03-13489,07901,072,14445.6%
2025-03-12557,4142421,111,59150.1%
2025-03-11482,642721,435,45733.6%
2025-03-101,172,3189632,048,06357.2%
2025-03-071,158,0373,0262,348,36649.3%
2025-03-06305,644238816,84437.4%
2025-03-05404,6881,3752,299,68317.6%
2025-03-04461,2281,182918,91350.2%
2025-03-03415,674864965,90843.0%
2025-02-28419,45001,079,60438.9%
2025-02-27554,6853,0681,529,59336.3%
2025-02-26572,4090940,05260.9%
2025-02-25854,37212,271,01237.6%
2025-02-243,056,0317273,722,22082.1%
2025-02-211,367,0777,7421,926,56871.0%
2025-02-203,611,304854,956,19172.9%
2025-02-191,871,98005,381,80534.8%
2025-02-18618,333931,409,72643.9%
2025-02-14473,7532321,972,78924.0%
2025-02-13603,2819101,169,03351.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.